Intermittent positive pressure breathing administration of terbutaline: a dose response study.
Eight patients with obstructive airways disease with a reversible component were treated with incremental doses of terbutaline by a Monaghan type nebulizer. Accumulative doses up to 3 mg were tolerated without significant side effects. Terbutaline appears to be safe and effective drug when administered by IPPB.